Listed

Emergent BioSolutions Inc.: Form 10-K for the period ended Dec 31, 2017

Filed with the SEC on Feb 23, 2018 and accepted by EDGAR at Feb 22, 2018, 18:00 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2017-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Gross profit3 months2017-10-01 to 2017-12-31$53.1mus-gaap:GrossProfit
Research and development12 months2017-01-01 to 2017-12-31$97.4mus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative12 months2017-01-01 to 2017-12-31$143.5mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income12 months2017-01-01 to 2017-12-31$124.3mus-gaap:OperatingIncomeLoss
Interest expense12 months2017-01-01 to 2017-12-31$6.6mus-gaap:InterestExpense
Income tax12 months2017-01-01 to 2017-12-31$36.0mus-gaap:IncomeTaxExpenseBenefit
Net income12 months2017-01-01 to 2017-12-31$82.6mus-gaap:NetIncomeLoss
Diluted EPS12 months2017-01-01 to 2017-12-31$1.71us-gaap:EarningsPerShareDiluted
Basic EPS12 months2017-01-01 to 2017-12-31$1.98us-gaap:EarningsPerShareBasic
Diluted shares (weighted)12 months2017-01-01 to 2017-12-3150,327,937 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow12 months2017-01-01 to 2017-12-31$208.1mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure12 months2017-01-01 to 2017-12-31$54.8mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Share repurchases12 months2017-01-01 to 2017-12-31$33.1mus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2017-12-31$178.3mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2017-12-31$485.4mus-gaap:AssetsCurrent
Total assetsAt period end2017-12-31$1.07bnus-gaap:Assets
Current liabilitiesAt period end2017-12-31$100.1mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2017-12-31$157.9mus-gaap:Liabilities
Long-term debtAt period end2017-12-31$13.5mus-gaap:LongTermDebtNoncurrent

Source: SEC EDGAR, the filing index for accession 0001367644-18-000014. Last ingested by Listed: Nov 4, 2026, 16:51 ET. Listed shows no prices and gives no investment advice.